ClinicalTrials.gg
Not yet recruitingNCT07936721Updated Nov 13, 2026

Gingival Enlargement Post-orthodontic Treatment

An observational study in Gingival Enlargement, sponsored by Texas A&M University. Not yet recruiting. Open to participants aged 11 Years to 21 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Texas A&M University · Observational

How we know

Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
11 Years to 21 Years
Sex
All
01

Study summary

The goal of this observational study is to evaluate spontaneous resolution of gingival enlargement which occurred during fixed orthodontic treatment.

Participants who completed orthodontic therapy will be recruited for the study, and morphological changes and related factors will be assessed.

Also online survey will be used to assess patient reported outcome regarding their gingival appearance.

02

Conditions studied

  • Gingival Enlargement

Keywords

  • orthodontic treatment
  • fixed orthodontic therapy
  • gingival enlargement
03

In context

Lead sponsor

Texas A&M University is the lead sponsor of 124 studies on the registry; 24 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 2 (29%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
11 Years to 21 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Graduate Orthodontic Clinic

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Modified Seymour Gingival Encroachment index ≥30% in the labial anterior sextants at the time the removal of fixed orthodontic appliances.
  • Age 11 to 19 at the time the fixed orthodontic appliances were first placed.
  • On fixed orthodontic appliances for a minimum of 18 months.

Exclusion criteria

Exclusion Criteria:

b. Exclusion criteria

  1. Active periodontitis, defined by the presence of clinical attachment loss (CAL) on any of the 12 anterior teeth at the time of orthodontic bracket debonding
  2. Does not have/does not use a smartphone (FOR QUALTRICS)
  3. Pregnant patients
  4. History of periodontal surgery
  5. Patients not able to give consent due to intellectual disabilities
  6. Patients with medication which can induce GE (e.g. calcium channel blockers, anticonvulsants/phenytoin, Ciclosporin)
  7. Subjects diagnosed with conditions which can present with GE (e.g. leukemia, vitamin C deficiency, plasma cell gingivitis, soft tissue pathology, hereditary gingival fibromatosis)

    • Patients with prominent defective restorations

      c. Exit criteria

    • Patients developing conditions that result in them meeting any of the above exclusion criteria (e.g., starting a medication that is known to affect the gingiva).
    • Patients requiring surgical periodontal therapy or other urgent treatment on the anterior sextants, at any time point during the study.
    • Patients unable or unwilling to continue in the study.
    • Patients missing the initial (3-7 weeks) postoperative visit.
    • Patients who fail to complete the questionnaire at the applicable visit.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Target follow-up
6 Months
Patient registry
Yes
Biospecimen retention
Samples without dna

Groups and cohorts

  • Adolescence who completed fixed orthodontic treatment

    Other: No intervention (observational study)

Interventions

  • OtherNo intervention (observational study)

    No intervention will be done during the study. It is strictly observational.

06

What researchers measure

Primary outcomes

  1. Change in Gingival Enlargement (GE) Index Score

    Enlargement of bucco-lingual direction scale (Seymour 1985), Extent of encroachment scale (Ellis 2021)

    Time frame: Day 0, 1 month, 6 months.

  2. Volumetric Changes in Buccal Gingival Tissue (m^3)

    Gingival volumetric changes in the anterior area will be compared using an intraoral scan where the scans will be overlayed to compare differences is volume change.

    Time frame: Day 0, 1 month, 6 months.

Secondary outcomes

  1. Patient reported outcome

    Patients will answer survey questions regarding their gingival appearance.

    Time frame: Day 0, 1 month, 6 months

  2. Changes in height of buccal papilla (mm)

    Changes in height of buccal papilla will be calculated in mm

    Time frame: Day 0, 1 month, 6 months

  3. Periodontal probing depth (PPD)

    PPD will be assessed using periodontal probe (mm)

    Time frame: Day 0, 1 month, 6 months

  4. Plaque Index (Silness & Löe, 1964)

    0 = No plaque. 1. = A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only by using the probe on the tooth surface. 2. = Moderate accumulation of soft deposits within the gingival pocket, or on the tooth and gingival margin which can be seen with the naked eye. 3. = Abundance of soft matter within the gingival pocket and/or on the gingival margin.

    Time frame: Day 0, 1 month, 6 months

  5. Gingival Index (Löe & Silness, 1963)

    0 = Absence of inflammation. 1. = Mild inflammation. Slight cliange in color and little change in texture. 2. = Moderate inflammation. Moderate glazing, redness, edema, and hypertrophy. Bleeding on pressure. 3. = Severe inflammation. Marked redness and hypertrophy. Tendency to spontaneous bleeding. Ulceration.

    Time frame: Day 0, 1 month, 6 months

  6. Gingival phenotype (Kan 2010)

    Outline of periodontal probe is visible = Thin Outline of periodontal probe is not visible = Thick

    Time frame: Day 0, 1 month, 6 months

  7. Crown width (CW)

    measured in mm

    Time frame: Day 0, 1 month, 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Zachrisson BU, Zachrisson S. Gingival condition associated with partial orthodontic treatment. Acta Odontol Scand. 1972 Mar;30(1):127-36. doi: 10.3109/00016357209004597. No abstract available. PubMed 4504433 ↗
  • Pinto AS, Alves LS, Zenkner JEDA, Zanatta FB, Maltz M. Gingival enlargement in orthodontic patients: Effect of treatment duration. Am J Orthod Dentofacial Orthop. 2017 Oct;152(4):477-482. doi: 10.1016/j.ajodo.2016.10.042. PubMed 28962731 ↗
  • Kouraki E, Bissada NF, Palomo JM, Ficara AJ. Gingival enlargement and resolution during and after orthodontic treatment. N Y State Dent J. 2005 Jun-Jul;71(4):34-7. PubMed 16146305 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2026; primary completion for May 2028, 18 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2026
First posted
Nov 13, 2026
StartEst.
Nov 15, 2026
Primary completionEst.
May 15, 2028
CompletionEst.
Oct 15, 2028
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07936721
Responsible party
Ying S. Wang (Clinical Assistant Professor, Texas A&M University) — Principal investigator
First posted
Nov 13, 2026
Start date
Nov 15, 2026 (estimated)
Primary completion
May 15, 2028 (estimated)
Completion
Oct 15, 2028 (estimated)
Last update
Nov 13, 2026

Study contacts

Ying S. Wang, DDS, MS
Contact
yswang@tamu.edu
2114-828-8282
Emma Dixon, DDS
Contact
emmadixon@tamu.edu

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion